T细胞浸润在肺腺癌发生中的意义以及与MicroRNA21的关系
[Abstract]:BACKGROUND The pathogenesis of lung cancer is still unknown, which is one of the causes of poor clinical prevention and treatment of lung cancer. Lung cancer has become a major dangerous disease endangering people's health. Signal transducers and activators of transcription (STAT) are many growth factors and thin cells in organisms. MicroRNA21 (microRNA21) is a non-coding small molecule RNA involved in the body's growth, metabolism, development and disease, and is associated with the occurrence, development, invasion and metastasis of a variety of tumors. The relationship between signal transduction among members of STAT family is becoming more and more interrelated, especially the interaction mechanism between microRNAs-21 and STAT3 signaling pathways is widely recognized. What is the significance of the Mi R-21/STAT3 signaling pathway in the development of lung cancer and the effect on T lymphocyte infiltration in the tumor environment? In this study, the expression of STAT3 and microRNA-21 in human lung adenocarcinoma was detected by quantitative real-time polymerase chain reaction (q RT-PCR), and the immersion of T4 and T8 cells in lung adenocarcinoma was detected by immunohistochemistry. Objective To investigate the relationship between the expression of STAT3 and microRNAs-21 in lung adenocarcinoma and the development of lung adenocarcinoma and the infiltration of T cells. Methods From June 2013 to June 2015, 46 specimens were collected from the Department of Laboratory Pathology, 91 Central Hospital of PLA, Department of Pathology, Jiaozuo People's Hospital, Henan Province. Lung adenocarcinoma tissues and paracancerous tissues, including 34 cases of metastatic carcinoma and 12 cases of normal lung tissues as negative control. The lung adenocarcinoma tissues, paracancerous tissues (about 2-5 cm away from the margin of the tumor tissue) and normal lung tissues were fresh tissue specimens and stored in refrigerator or liquid nitrogen at - 80 C. Lung adenocarcinoma tissues, paracancerous tissues The specimens collected did not include patients with lung adenocarcinoma who had undergone chemotherapy before operation or patients with recurrent lung adenocarcinoma. Results 1 46 cases of lung adenocarcinoma tissues were collected by routine pathological diagnosis, including 34 cases of lymph node metastatic carcinoma, 12 cases of normal lung tissues as control. All tissues were pathologically diagnosed. 2 STAT3 mRNA expression was detected by Q RT-PCR. The results of AT3 mRNA expression in the above tissues were as follows: normal lung tissue was 0.319+0.015; paracancerous tissue was 0.631+0.020; lung adenocarcinoma tissue was 1.046+0.042; metastatic cancer tissue was 1.235+0.015. There were significant differences in gene expression between normal lung tissue, para-lung cancer tissue, lung adenocarcinoma tissue and metastatic cancer tissue (P 0.01). The expression of STAT3 gene in lung adenocarcinoma was significantly higher than that in normal and adjacent tissues (P 0.01). 3 The expression of microRNA-21 in lung adenocarcinoma and normal lung tissues was detected by qRT-PCR. The results showed that the expression of microRNA-21 in all kinds of tissues in normal group was 0.0018 (+0.001). There were significant differences between normal lung tissues and lung adenocarcinoma tissues (P 0.01). There were significant differences between lung adenocarcinoma and metastatic carcinoma tissues (P 0.05). The expression of microRNA-21 in normal lung tissues was low, and that in lung adenocarcinoma tissues was high (P 0.05). The proportion of CD3 +, CD4 +, CD8 + lymphocytes in tumor tissues was 76.12% in normal tissues. The number of CD3 + cells in tumor tissues was 76.12% in paracancerous group and normal group. There was no significant change in paracancerous group, but the number of CD4 + cells in adenocarcinoma group was significantly decreased. The proportion of CD4 + cells in normal group was 45.17%, and that in paracancerous and adenocarcinoma group was lower than normal group. The number of CD8 + cells in normal group was 28.78%, and that in adenocarcinoma group was higher than that in normal group, P 0.05. Conclusion The occurrence and evolution of lung adenocarcinoma may be related to the increase of microRNA-21 and the disturbance of immune function in vivo.
【学位授予单位】:新乡医学院
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R734.2
【相似文献】
相关期刊论文 前10条
1 常秀青 ,Tony Sheldon;低焦油含量香烟与肺腺癌发病率上升有关[J];英国医学杂志(中文版);2002年01期
2 邓小梅,何权瀛;细支气管肺泡细胞癌与其他类型肺腺癌的对比分析[J];中国呼吸与危重监护杂志;2005年03期
3 杨长青;王莲芳;;飞行人员右肺腺癌1例[J];海军医学杂志;2006年04期
4 陈小兵;闫明;罗素霞;李宁;邹宏志;韩黎丽;;84例青年肺腺癌早期误诊原因分析[J];实用诊断与治疗杂志;2007年09期
5 陈小兵;闫明;曾军杰;罗素霞;;青年女性肺腺癌首发症状及早期误诊原因分析[J];中国现代医生;2009年06期
6 周琪;段亮;姜格宁;丁嘉安;;青年男性肺腺癌临床特征对预后的影响[J];中国癌症杂志;2009年08期
7 张文丽;;以高热为首发症状的肺腺癌病例并文献复习[J];甘肃医药;2013年07期
8 郭哲;肺腺癌病人的预防性头颅照射[J];国外医学(肿瘤学分册);1988年06期
9 刘福升,,李险峰,杨爱民,王彤;肺腺癌误诊肺结核16例分析[J];中国防痨杂志;1994年01期
10 余伟江;放疗及合并化疗治疗Ⅲ期肺腺癌疗效分析[J];肿瘤防治研究;1994年04期
相关会议论文 前10条
1 孙强;顾春东;雷霆;王金;李锦绣;;浸润性周围型小肺腺癌(≤2cm)不同病理亚型的比较[A];第13届全国肺癌学术大会论文汇编[C];2013年
2 袁明远;;周围型肺腺癌病灶的放射学分类及其临床价值[A];中华医学会第16次全国放射学学术大会论文汇编[C];2009年
3 顾国浩;;生物芯片在肺腺癌诊断中的应用进展[A];中华医学会第八次全国检验医学学术会议暨中华医学会检验分会成立30周年庆典大会资料汇编[C];2009年
4 林嘉颖;吴一龙;杨学宁;乔贵宾;王坤;陈刚;;不同预后的肺腺癌患者酪氨酸激酶信号传导通路异常的初步探讨[A];第三届中国肿瘤学术大会教育论文集[C];2004年
5 汤秀英;吴立红;张烨;;肺腺癌的超微观察及异质性探讨[A];第八次全国电子显微学会议论文摘要集(Ⅰ)[C];1994年
6 徐芝君;应可净;;胸部CT基本正常肺腺癌伴慢性DIC一例并文献复习[A];浙江省医学会呼吸系病分会成立三十周年庆典活动暨2008年呼吸病学学术年会论文汇编[C];2008年
7 邵艳;洪伟俊;宁允叶;胥武剑;李强;;肺腺癌恶性转化相关蛋白的初步筛查[A];中华医学会呼吸病学年会——2011(第十二次全国呼吸病学学术会议)论文汇编[C];2011年
8 王恩华;;解读及评价国际多学科肺腺癌分类[A];2012年浙江省病理学学术年会论文集[C];2012年
9 宋正波;朱慧能;郭振英;吴伟;孙文勇;张沂平;;肺腺癌新分类在预测Ⅰ期非小细胞肺腺癌预后中的价值[A];第13届全国肺癌学术大会论文汇编[C];2013年
10 赵燕妮;曹菊;牟向东;阙呈立;;肺腺癌影像反复波动病例报告一例并文献复习[A];中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议论文汇编[C];2013年
相关重要报纸文章 前8条
1 丁香;日发现肺腺癌的预测因子[N];中国医药报;2007年
2 仇逸邋孙国根;吸烟丈夫的妻子,患肺腺癌风险高[N];新华每日电讯;2007年
3 曾理;肺腺癌早诊研究关注“起源”[N];健康报;2008年
4 记者 李天舒 胡德荣;为何不吸烟者也患肺癌[N];健康报;2010年
5 记者 胡德荣;非吸烟肺腺癌人群致癌基因突变谱建立[N];健康报;2011年
6 高原;或与MiR-21分子有关[N];广东科技报;2009年
7 海飞鱼;探索肺癌突变基因[N];医药经济报;2008年
8 健康时报记者 王志胜;一样的肿瘤,不一样治法[N];健康时报;2009年
相关博士学位论文 前10条
1 孙正亮;肺腺癌的分子分型特征及其与病理分型的关联研究[D];复旦大学;2014年
2 朱聪惠;miR-183负调控下游靶基因PTPN4促进肺腺癌始动细胞侵袭迁移作用的研究[D];第三军医大学;2016年
3 董瑜;中国人群肺腺癌驱动基因表达与临床特征及预后的相关性研究[D];上海交通大学;2013年
4 潘元威;肺部局灶性磨玻璃结节的~(18)F-FDG PET/CT表现与组织病理及EGFR基因突变的相关性研究[D];郑州大学;2016年
5 杨欣;肺腺癌预后相关的临床病理因素分析及分子病理研究[D];北京协和医学院;2014年
6 郑华;筛选肺腺癌相关血清自身抗体标志物[D];北京市结核病胸部肿瘤研究所;2010年
7 张扬;肺腺癌致癌基因突变研究[D];复旦大学;2013年
8 张丽;基于IASLC/ATS/ERS国际多学科新分类的肺腺癌影像学及相关研究[D];北京协和医学院;2014年
9 杨继要;肺腺癌肿瘤相关抗原的筛选鉴定及克隆表达[D];郑州大学;2006年
10 何萍;染色体15q25.1区域基因多态性与中国南方人群肺腺癌易感性的关联研究[D];南方医科大学;2014年
相关硕士学位论文 前10条
1 卜静;顺铂联合雷帕霉素、3-MA对肺腺癌A549细胞及其裸鼠原位移植瘤的影响[D];河北医科大学;2015年
2 Suraj Tamang(苏拉杰塔芒);肺部呈GGN表现的非浸润性病变与浸润性肺腺癌的CT征象对比研究[D];大连医科大学;2015年
3 张晔;1.5T磁共振表观扩散系数早期监测肺腺癌靶向治疗疗效的临床价值[D];苏州大学;2015年
4 杨太平(Prashanta Acharya);肺腺癌伴结节GGO:HRCT影像学和病理学的相关性[D];东南大学;2015年
5 宋雪薇;肺腺癌血清肿瘤标志物与EGFR突变及TKIs疗效的相关性研究[D];大连医科大学;2015年
6 明星;肺磨玻璃结节CT征象对早期肺腺癌诊断价值的Meta分析[D];遵义医学院;2016年
7 孟谊;CastPCR法检测EGFR驱动突变在肺癌中的初步应用探讨[D];南京大学;2015年
8 任保瑞;ⅠB-ⅢA期肺腺癌患者中EGFR、KRAS基因突变状态对术后应用培美曲塞联合铂类辅助化疗疗效的影响[D];安徽医科大学;2016年
9 孔丽丽;肺腺癌中EZH2、MMP-28的表达和EGFR突变的关系及临床意义[D];吉林大学;2016年
10 周欣可;双源CT双能量成像技术与肺腺癌病理分级相关性及其价值的初步研究[D];广西医科大学;2016年
本文编号:2199147
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2199147.html